TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
BioSalma AB
Closing information (x1000 EUR)
Closing information | 2024/08 | 2023/08 | 2022/08 |
Turnover |
6,747
|
4,840 | |
Financial expenses |
0
|
1 | |
Earnings before taxes |
1,424
|
1,171 | |
EBITDA |
1,431
|
1,180 | |
Total assets |
4,121
|
3,095 | |
Current assets |
4,107
|
3,080 | |
Current liabilities |
1,644
|
787 | |
Equity capital |
2,477
|
2,152 | |
- share capital |
4
|
5 | |
Employees (average) |
6
|
5
|
4 |
Financial ratios
Fiscal year | 2024/08 | 2023/08 | 2022/08 |
Solvency |
60.1%
|
69.5% | |
Turnover per employee |
1,349
|
1,210 | |
Profit as a percentage of turnover |
21.1%
|
24.2% | |
Return on assets (ROA) |
34.6%
|
37.9% | |
Current ratio |
249.8%
|
391.4% | |
Return on equity (ROE) |
57.5%
|
54.4% | |
Change turnover |
2,381
|
1,059 | |
Change turnover % |
38%
|
55%
|
28% |
Chg. No. of employees |
1
![]() |
1
|
0 |
Chg. No. of employees % |
20%
|
25%
|
0% |
Total value of public sale
Fiscal year | 2024/08 | 2023/08 | 2022/08 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.